ArticleMembranes2022
Feasibility of Poly (Vinyl Alcohol)/Poly (Diallyldimethylammonium Chloride) Polymeric Network Hydrogel as Draw Solute for Forward Osmosis Process.
Article in Membranes, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed, 8 citations in OpenAlex.
- Synthesis of sodium alginate / polyvinyl alcohol / polyethylene glycol semi-interpenetrating hydrogel as a draw agent for forward osmosis desalination.BMC chemistry · 2024Article
- Synthesis and characterization of an innovative sodium alginate/polyvinyl alcohol bioartificial hydrogel for forward-osmosis desalination.Scientific reports · 2024Article
- State-of-the-Art of Polymer/Fullerene CMembranes · 2022Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 2 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Forward osmosis (FO) has been identified as an emerging technology for the concentration and crystallization of aqueous solutions at low temperatures. However, the application of the FO process has been limited due to the unavailability of a suitable draw solute. An ideal draw solute should be able to generate high osmotic pressure and must be easily regenerated with less reverse solute flux (RSF). Recently, hydrogels have attracted attention as a draw solution due to their high capacity to absorb water and low RSF. This study explores a poly (vinyl alcohol)/poly (diallyldimethylammonium chloride) (PVA-polyDADMAC) polymeric network hydrogel as a draw solute in forward osmosis. A low-pressure reverse osmosis (RO) membrane was used in the FO process to study the performance of the hydrogel prepared in this study as a draw solution. The robust and straightforward gel synthesis method provides an extensive-scale application. The results indicate that incorporating cationic polyelectrolyte poly (diallyldimethylammonium chloride) into the polymeric network increases swelling capacity and osmotic pressure, thereby resulting in an average water flux of the PVA-polyDADMAC hydrogel (0.97 L m−2 h−1) that was 7.47 times higher than the PVA hydrogel during a 6 h FO process against a 5000 mg L−1 NaCl solution (as a feed solution). The effect of polymer and cross-linker composition on swelling capacity was studied to optimize the synthesized hydrogel composition. At 50 °C, the hydrogel releases nearly >70% of the water absorbed during the FO process at room temperatures, and water flux can be recovered by up to 86.6% of the initial flux after 12 hydrogel (draw solute) regenerations. Furthermore, this study suggests that incorporating cationic polyelectrolytes into the polymeric network enhances FO performances and lowers the actual energy requirements for (draw solute) regeneration. This study represents a significant step toward the commercial implementation of a hydrogel-driven FO system for the concentration of liquid-food extract.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.